PRN: $47.08 Billion Cell Analysis Market - Global Forecast to 2023 - Research and Markets

17/feb/2017 17.10.19 PR Newswire Turismo Contatta l'autore

$47.08 Billion Cell Analysis Market - Global Forecast to 2023 - Research and Markets

 
[17-February-2017]
 

DUBLIN, Feb. 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Cell Analysis Global Market - Forecast to 2023" report to their offering.

The cell analysis market is expected to grow at high single digit CAGR to reach $47,088 million by 2023.

The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds, and grants, availability of reagents and cell analysis instruments are driving the growth of the market.

However, the major market restraints include high capital investments and a shortage of skilled labor for the high content screening procedure.

The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment.

The cell analysis global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares.

The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions.


Factors Influencing Market

Drivers and Opportunities

  • Rising Incidence of Life Threatening Infectious Diseases
  • Increasing Government, Corporate Funding and Investment in Cell Based Research
  • Introduction of Enhanced Cell Imaging and Analysis System Reduces The Cost and Time Consumption for Drug Discovery Process
  • Availability of Advanced Cell Analysis Instruments
  • Increasing Demand for Cell Analysis Products by End Users
  • Emerging Asia Pacific Cell Analysis Market
  • Increased Availability of Cell Analysis Service Providers
  • Automation in Oncology Research for Early Diagnosis

Restraints & Threats

  • Lack of Skilled Personnel to Perform High Content Screening
  • Expensive Cell Analysis Instruments
  • Stringent Regulatory Framework Limits Advancements in Cellular Analysis Market
  • Patents or Ipr Issues Hindering the Cell Analysis Market

Companies Mentioned

- 4titude (U.K.)
- AB Sciex (U.S.)
- Abbott Laboratories, Inc. (U.S.)
- Abcam PLC (U.S.)
- Abdos (India)
- Abnova Corporation (Taiwan)
- ACEA Bioscience, Inc (U.S.)
- Active Motif (U.S.)
- Adnagen (U.S.)
- Advanced Cell Diagnostics (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Alere (U.S.)
- Analytik Jena AG (Germany)
- Apocell (U.S.)
- Applied Microarrays (U.S.)
- Ausragen (U.S.)
- Auxilab S.L (Spain)
- Avantes BV (Netherlands)
- Aven Inc (U.S.)
- Aviva Bioscience (U.S.)
- Becton Dickinson and Company (U.S.)
- BGI (China)
- Bibby Scientific Limited (U.K.)
- Bio Care Medical LLC (U.S.)
- BioDot Inc. (U.S.)
- Biofluidica (U.S.! )
- Biologics (China)
- BioMerieux SA (Germany)
- Bio-Rad Laboratories (U.S.)
- Bioron (France)
- Biosearch Technologies (U.S.)
- BioView (Israel)
- BMS microscopes (Netherlands)
- Bruker (U.S.)
- Canopus Bioscience (U.S.)
- Capp ApS (Denmark)
- Carl Zeiss AG (Germany)
- Cell Signaling Technology, Inc. (U.S.)
- Cell-Vu (U.S.)
- Cherry Biotech (France)
- Cisbio Bioassays (France)
- Clearbridge BioMedics (Singapore)
- Corning Inc (U.S.)
- Creatv Microtech inc (U.S.)
- Cyflogic (Finland)
- Cynvenio Biosystems (U.S.)
-! Cytogno s S.L. (Spain)
- DaAn Gene (China)
- Danaher Corporation (U.S.)
- Danish Micro Engineering (Denmark)
- Diagenode (Netherlands)
- DiscoveRx (U.S.)
- Domel (Slovenia)
- Dragon Laboratory Instruments Ltd (China)
- eBioscience, Inc., (U.S.)
- Eppendorf (Germany)
- Etaluma, Inc (U.S.)
- Eurofins Scientific (Luxembourg)
- EXIQON (Denmark)
- FEI Company (U.S.)
- Fluidgm Corporation (U.S.)
- Fluxion Biosciences (U.S.)
- GE Healthcare (U.K.)
- Genedata AG (Switzerland)
- Genemed Biotechnologies Inc (U.S.)
- General Biologicals (Taiwan)
- Gyros AB (Sweden)
- Handyem (Canada)
- Hausser Scientific (U.S.)
- Herolab GmbH (Germany)
- Hettich lab technology (Germany)
- Hoffmann-La Roche (Switzerland)
- HORIBA, Ltd. (Japan)
- Illumina (U.S.)
- Immunodiagnostics systems (France)
- Jasco (U.S.)
- Jena Biosciences (Germany)
- JEOL, Ltd. (Japan)
- Jasco Analytical Instruments (U.S.)
- Kapa Biosystems (U.S.)
- Keyence Corporation (U.S.)
- Kyratec (Australia)
- Labcon (U.S.)
- Labnet International, Inc (U.S.)
- Lubio Science (Switzerland! )
- Luminex Corporation (U.S.)
- LW Scientific (U.S.! )
- Macrogen Inc (South Korea)
- Medical Econet (Austria)
- Meijo techno (U.K.)
- Merck KGaA (Germany)
- Mettler-Toledo, Inc. (U.S.)
- Micro-shot Technology Ltd (China)
- Miltenyil Biotec (Germany)
- Nanostring Technologies (U.S.)
- New England Biolabs (U.S.)
- Nikon Corporation (Japan)
- Olympus Corporation (Japan)
- Optika SRL., (Italy)
- Ortho Clinical Diagnostics (U.S.)
- Ortoalresa (Spain)
- Oxford Nanopore Technologies, Ltd. (U.K.)
- Pacific Biosciences (U.S.)
- Panagene (South Korea)
- Park Systems (Korea)
- PerkinElmer Inc (U.S.)
- Pheonix (U.S.)
-! PicoQuant GmbH (Germany)
- Promega Corporation (U.S.)
- Qiagen N.V. (Netherlands)
- Quest Diagnostics (U.S.)
- R&D Systems (U.S.)
- Rain Dance Technologies (U.S.)
- Rheonix (U.S.)
- Rigaku Corporation (Japan)
- RR Mechatronics (Netherlands)
- Sacace Biotechnologies (Italy)
- Sanyo (Japan)
- Scienion (Germany)
- Scientific Specialities Inc (U.S.)
- Seegene (South Korea)
- Seimens Healthcare (Germany)
- Separation Technology, Inc (U.S.)
- Shimadzu Scientific Instruments (Japan)
- Sigma Laborzentrifugen GmbH (Germany)
- Sohn Gm! bH (Germany)
- Sony Biot! echnolog y (U.S.)
- Sprenson Bioscience (U.S.)
- Stemcell Technologies (Canada)
- Sysmex (Japan)
- Tecan (Switzerland)
- The Western Electric & Scientific Works (India)
- ThermoFisher Scientific Inc (U.S.)
- Thorlabs (U.S.)
- Toyo Gosei Co., Ltd (Japan)
- TrimGen Genetic Diagnostics (U.S.)
- Vision Scientific Co Ltd (Korea)
- Visitron Systems Gmbh (Germany)
- Waters Corporation (U.S.)
- Yokogawa Electric Corporation (Japan)
- Zymo Research (U.S.)

For more information about this report visit http://www.researchandmarkets.com/research/ngm5k6/cell_analysis

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl